May 11, 2026 - 10:36

Lincoln National Corporation reported first-quarter 2026 results earlier this month, posting revenue of $5.31 billion. The company recorded a net loss of $172 million, an improvement from the larger loss it reported in the same period last year. Despite the continued loss, Lincoln maintained its common and preferred dividend payments, signaling confidence in its cash position and long-term strategy.
In a separate development, Centro Benefits Research expanded its API integration with Lincoln Financial. The new link automates the exchange of Request for Proposal data, a move designed to simplify broker workflows. The integration targets Lincoln's Group Protection segment, where efficiency gains could support faster, more cost-effective growth.
Together, the narrower loss and the technology partnership suggest Lincoln is focusing on operational discipline while modernizing how it interacts with benefits brokers. The API deal may help Lincoln win more business by reducing manual data entry and speeding up quote turnaround times. For investors, the combination of a stabilizing bottom line and a push toward digital efficiency could reshape the narrative around the stock, shifting attention from legacy risks to incremental improvements in core operations.
May 10, 2026 - 20:14
A Florida Salesperson Thought He Was Helping People Go Solar. Now He Complains To Dave Ramsey He's Really Selling Loans, Not Solar PanelsA Florida man who thought he was joining the solar industry to help people save money and the environment says he quickly discovered the real job was selling loans, not panels. He brought his...
May 10, 2026 - 04:02
AMETEK Bets $5 Billion on Indicor Deal to Boost Industrial Tech PortfolioAMETEK has announced a definitive agreement to buy the Instrumentation group of businesses from Indicor, LLC for $5 billion in cash. The company`s management called the acquisition a highly...
May 9, 2026 - 04:47
What Damora Therapeutics (DMRA)'s CEO Shake-Up and Finance Refresh Means For ShareholdersDamora Therapeutics has announced a significant shake-up in its executive ranks, appointing Jennifer Jarrett as the new President and CEO. In a parallel move, the company named Brian Burkavage as...
May 8, 2026 - 22:44
Futures Traders Are Raising the Odds of a Fed Hike This Year. What Does That Mean for the Market?Traders in the futures market are now pricing in a greater probability that the Federal Reserve will raise interest rates before the end of the year. This shift in expectations marks a notable...